Recently active
Unread page 7
On the live site this tab tracks what you have not read. In this static rendering it shows every topic with activity in the last 45 days, which is the closest honest equivalent — we would rather explain the difference than pretend a static page knows your reading history.
414 topics · page 7 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
[2026 update] Comparing prices across jurisdictions without misleading yourself
On the subject in the title: Comparing prices across jurisdictions without misleading yourself Working notes rather than a conclusion. Comparing prices across jurisdictions keeps being re-asked here and I…
|
2 | 809 | 23h | |
|
Why a pen's dose steps are fixed and what that costs you
The question in the title: Why a pen's dose steps are fixed and what that costs you I will give what I have already checked below so nobody repeats it. A question about a device rather than about a compound,…
|
4 | 2.5k | 23h | |
|
What "marked as solution" means and who gets to mark it
Asking directly, because I could not find a straight answer: What "marked as solution" means and who gets to mark it Question in the title. Context below, and I have tried to include the things people here…
|
2 | 290 | 1d | |
|
Tracking semaglutide's approved indications across jurisdictions, dated
Tracking semaglutide's approved indications across jurisdictions, dated Writing it up because I had to work it out twice and would rather nobody else did. Putting the numbers in the first post, because a…
|
+15 | 19 | 2.8k | 1d |
|
Historical amylin analogues and what happened to them
Posting this under the heading it deserves: Historical amylin analogues and what happened to them Everything below is what sits behind that. Proposing that historical amylin analogues deserves a maintained…
|
+29 | 36 | 31k | 1d |
|
What steady state means for the decision to escalate
What steady state means for the decision to escalate — that is the question, and I have not found it answered plainly anywhere I have looked. A question about steady state that I think has a definite answer,…
|
+31 | 35 | 2k | 1d |
|
MS/MS sequence confirmation: what it costs and when it is worth it
MS/MS sequence confirmation: what it costs and when it is worth it — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it…
|
+2 | 6 | 2.7k | 1d |
|
Pooling trials with different estimands
On the subject in the title: Pooling trials with different estimands Working notes rather than a conclusion. Asking about pooling trials with different estimands on behalf of the question I keep seeing asked…
|
+120 | 132 | 2.3k | 1d |
|
A structured critique template this community uses
A structured critique template this community uses — setting out what I have, and where I think it stops being reliable. Structured critique template — I have the observation and I do not trust my…
|
2 | 18k | 1d | |
|
Selection into a registry and what it does to the estimate — a second dataset
Posting this under the heading it deserves: Selection into a registry and what it does to the estimate — a second dataset Everything below is what sits behind that. Posting a small dataset on Selection. It is…
|
+28 | 32 | 1.3k | 1d |
|
Peer-to-peer review: what actually happens on the call
On the subject in the title: Peer-to-peer review: what actually happens on the call Working notes rather than a conclusion. The question about peer-to-peer review that I actually want answered is the second…
|
2 | 1.2k | 1d | |
|
Micro-titration: a disputed topic, argued properly — one year on
Posting this under the heading it deserves: Micro-titration: a disputed topic, argued properly — one year on Everything below is what sits behind that. Reading back through what has been written here about…
|
+63 | 68 | 35k | 1d |
|
Completing a dose with a second syringe, and the dead-volume arithmetic
Posting this under the heading it deserves: Completing a dose with a second syringe, and the dead-volume arithmetic Everything below is what sits behind that. I have read the maintained page on this and I…
|
+65 | 76 | 7.4k | 1d |
|
Travelling with an injectable: documentation and practicalities
Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting a stated criterion rather than an outcome,…
|
+37 | 42 | 2.1k | 1d |
|
Reading U-100 graduations, with a conversion table
Posting this under the heading it deserves: Reading U-100 graduations, with a conversion table Everything below is what sits behind that. A question about reading U-100 graduations that I think has a definite…
|
+35 | 41 | 2k | 1d |
|
Tesamorelin has an approved indication — what that changes about the evidence
Tesamorelin has an approved indication — what that changes about the evidence — setting out what I have, and where I think it stops being reliable. What changes if the standard account of tesamorelin is…
|
+23 | 27 | 3.4k | 1d |
|
Coming back to: Why I now write the concentration on the vial in marker
The question in the title: Why I now write the concentration on the vial in marker I will give what I have already checked below so nobody repeats it. Writing this out with the numbers in it, because…
|
+8 | 12 | 4.3k | 1d |
|
Revisiting: Taste changes and food aversion, reported and discussed
Revisiting: Taste changes and food aversion, reported and discussed Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers…
|
+20 | 25 | 4.3k | 1d |
|
Subgroup analyses: pre-specified versus discovered
Subgroup analyses: pre-specified versus discovered — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with the settled view on subgroup analyses, and I…
|
2 | 27k | 1d | |
|
[2026 update] Journal club: what we got wrong in an earlier session
Journal club: what we got wrong in an earlier session — setting out what I have, and where I think it stops being reliable. Bringing a claim rather than a paper, because the claim is the thing circulating.…
|
+5 | 9 | 4.2k | 1d |
|
Packaging that arrived damaged: documenting it properly
Packaging that arrived damaged: documenting it properly Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
|
+43 | 49 | 26k | 1d |
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Trying to work out what would count…
|
+17 | 22 | 4.5k | 1d |
|
What changed in 2026, by region — does this still hold?
What changed in 2026, by region — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in…
|
+20 | 25 | 50k | 1d |
|
Follow-up: Signs of dehydration worth acting on
Posting this under the heading it deserves: Signs of dehydration worth acting on Everything below is what sits behind that. A follow-up question about Signs of dehydration worth acting that I did not know to…
|
+35 | 39 | 9.8k | 1d |
|
Asking a follow-up: new topic or new reply?
Asking a follow-up: new topic or new reply? — that is the question, and I have not found it answered plainly anywhere I have looked. Collecting what is known about asking a follow-up in one place, because it…
|
+68 | 73 | 40k | 1d |
|
BPC-157: what the rodent literature actually shows, and what it does not — does this still hold?
The question in the title: BPC-157: what the rodent literature actually shows, and what it does not — does this still hold? I will give what I have already checked below so nobody repeats it. I would like to…
|
+6 | 10 | 3.1k | 1d |
|
Coming back to: Where the four-week escalation interval comes from, and what it is not
Posting this under the heading it deserves: Where the four-week escalation interval comes from, and what it is not Everything below is what sits behind that. Four-week escalation interval — I have the…
|
+44 | 48 | 11k | 1d |
|
How much of the diluent volume the powder itself displaces
Asking directly, because I could not find a straight answer: How much of the diluent volume the powder itself displaces Writing this out with the numbers in it, because "roughly" is how these go wrong. Vial:…
|
2 | 1.8k | 1d | |
|
Coming back to: Storing in the door of the fridge is worse than you think
On the subject in the title: Storing in the door of the fridge is worse than you think Working notes rather than a conclusion. Asking about the failure mode rather than the procedure, because the procedure is…
|
+2 | 6 | 2.1k | 1d |
|
Hair shedding at month three: mechanism and time course — the long version
Hair shedding at month three: mechanism and time course — the long version Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here…
|
+50 | 54 | 50k | 1d |